• Server Updates
    We will be completing server updates between 3:00 - 6:00 AM Eastern on Wednesday, March 23. Thanks for your patience while we improve SDN!

Flecainide

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

chromuffin

Full Member
7+ Year Member
Joined
Jan 24, 2017
Messages
608
Reaction score
324
Points
3,311
  1. Medical Student
Advertisement - Members don't see this ad
I haven't found a good source on this. Does Flecainide cause QT prolongation? I had a discussion with a classmate the other day and he swore up and down that flecainide didn't cause QT prolongation because it was an Ic antiarrhythmic but Flecainide inhibits K+ channels....

Would love to have a source for this..
 
Class I drugs are Na+ blockers, not K+ blockers, although Ia has the additional effect of blocking K+, which increases QT. Flecainide is a Ic, and does not block K+ channels, thus it will not prolong QT.
 
Class I drugs are Na+ blockers, not K+ blockers, although Ia has the additional effect of blocking K+, which increases QT. Flecainide is a Ic, and does not block K+ channels, thus it will not prolong QT.
My class notes state flecainide "blocks a K+ current involved in depolarization and prolongs action potential duration in the ventricles"
 
By definition, Class I antiarrhythmic's primary mechanism of action is Na+ channel blockade. Some also block the K+ channel significantly (i.e. Class Ia), while other do to a much lesser extent, if at all (i.e. Class Ic).

Here's a link to an article where someone felt that it was rare enough to get torsades with flecainide, that it warranted a case report: http://onlinelibrary.wiley.com/doi/10.1002/phar.1403/abstract

Also, see here:
http://emedicine.medscape.com/artic...i3V2zxLFOu9AF/HZt4/lJoichrzF/7vlnSF6AEX/09M8=
"Ia - Quinidine, procainamide, disopyramide (depress phase 0, prolonging repolarization)
Ib - Lidocaine, phenytoin, mexiletine (depress phase 0 selectively in abnormal/ischemic tissue, shorten repolarization)
Ic - Flecainide, propafenone, moricizine (markedly depress phase 0, minimal effect on repolarization"

In summary, flecainide likely has minimal blockade on K+ channels that in rare cases can cause prolonged QT. For Step I purposes (and as per First Aid), only classes Ia and III have significant K+ channel blockade, and therefore can prolong QT.
 
By definition, Class I antiarrhythmic's primary mechanism of action is Na+ channel blockade. Some also block the K+ channel significantly (i.e. Class Ia), while other do to a much lesser extent, if at all (i.e. Class Ic).

Here's a link to an article where someone felt that it was rare enough to get torsades with flecainide, that it warranted a case report: http://onlinelibrary.wiley.com/doi/10.1002/phar.1403/abstract

Also, see here:
http://emedicine.medscape.com/article/2172024-overview?pa=LdlepnQBnb9AIg6HQDBS3zmjLwleUtR6PHr/CdtsVfdmZehiWt2C02zj+ypef3Ni3V2zxLFOu9AF/HZt4/lJoichrzF/7vlnSF6AEX/09M8=
"Ia - Quinidine, procainamide, disopyramide (depress phase 0, prolonging repolarization)
Ib - Lidocaine, phenytoin, mexiletine (depress phase 0 selectively in abnormal/ischemic tissue, shorten repolarization)
Ic - Flecainide, propafenone, moricizine (markedly depress phase 0, minimal effect on repolarization"

In summary, flecainide likely has minimal blockade on K+ channels that in rare cases can cause prolonged QT. For Step I purposes (and as per First Aid), only classes Ia and III have significant K+ channel blockade, and therefore can prolong QT.
I'm aware of the classes and their typical presentation. This is precisely why I made the post. Flecainide CAN induce torsades, so should it be contraindicated in, say, a patient with congenital long QT? Perhaps I don't understand what qualifies as step question..
 
Top Bottom